Ian S. Mitchell,James F. Blake,Rui Xu,Nicholas C. Kallan,Dengming Xiao,Keith Lee Spencer,Josef R. Bencsik,Eli M. Wallace,Stephen T. Schlachter,Anna L. Leivers,Jun Liang,Brian Safina,Birong Zhang,Chris
申请号：
US15670874
公开号：
US20180169099A1
申请日:
2017.08.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I:Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
